Clinical diagnosis and treatment of mastalgia

doi:10.3877/cma.j.issn.1674-0793.2020.01.019

Abstract

Abstract:

Mastalgia is the most commonly medical cause of breast diseases among women aged 30-50 years, and 10%-20% patients suffer from severe mastalgia. Patients are mainly concerned about mastalgia as the first symptom of breast cancer and fear of malignant changes, and severe mastalgia seriously affects the quality of their life. However, the etiologies of mastalgia are not well-known, and there are no unified treatments for mastalgia. In summary, this article mainly focuses on the etiologies, classification, risk of malignant changes, diagnosis and treatment of mastalgia, and provides reference for diagnosis and treatment of mastalgia.

Key words: Breast diseases, Hyperplasia, Mastalgia

Xiongxiong Li, Yu Ren, Ting Xu, Jin Shang. Clinical diagnosis and treatment of mastalgia[J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(01): 60-63.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2020.01.019

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2020/V14/I01/60

Figures/Tables 2

References 23

[1]	Salzman B, Fleegle S, Tully AS. Common breast problems[J]. Am Fam Physician, 2012, 86(4): 343-349.
[2]	吕晖，周炜，李然伟, 等. 腹针治疗乳腺增生临床疗效观察[J]. 中国针灸, 2013, 33(9): 843-846.
[3]	中华预防医学会妇女保健分会乳腺保健与乳腺疾病防治学组. 乳腺增生症诊治专家共识[J]. 中国实用外科杂志, 2016, 36(7): 759-762.
[4]	段学宁. 乳腺良性疾病诊治共识与争议[J]. 中国实用外科杂志 2016, 36(7): 713-715.
[5]	Iddon J, Dixon JM. ABC of Breast Diseases, 4th ed[M]. London: The BMJ, 2013: 25-31.
[6]	Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain[J]. Mayo Clin Proc, 2004, 79(3): 353-372.
[7]	Ader DN, South-Paul J, Adera T, et al. Cyclical mastalgia: prevalence and associated health and behavioral factors[J]. J Psychosom Obstet Gynaecol, 2001, 22(2): 71-76.
[8]	Morrow M. The evaluation of common breast problems[J]. Am Fam Physician, 2000, 61(8): 2371-2378.
[9]	Lumachi F, Ermani M, Brandes AA, et al. Breast complaints and risk of breast cancer. Population-based study of 2 879 self-selected women and long-term follow-up[J]. Biomed Pharmacother, 2002, 56(2): 88-92.
[10]	Deniz K, Serife K, Belgin A, et al. Mastalgia and associated factors: A cross-sectional study[J]. AGRI, 2017, 29(3): 100-108.
[11]	Tejwani PL, Srivastava A, Nerkar H, et al. Centchroman regresses mastalgia: A randomized comparison with danazol[J]. Indian J Surg, 2011, 73(3): 199-205.
[12]	Eren T, Aslan A, Ozemir IA, et al. Factors effecting mastalgia[J]. Breast Care （Basel）, 2016, 11(3): 188-193.
[13]	Johnson KM, Bradley KA, Bush K, et al. Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes[J]. J Gen Intern Med, 2006, 21 Suppl 3: S70-S75.
[14]	Santen RJ, Mansel R. Benign breast disorders[J]. N Engl J Med, 2005, 353(3): 275-285.
[15]	Yıldırım AC, Yıldız P, Yıldız M,et al. Mastalgia-cancer relationship: A prospective study[J]. J Breast Health, 2015, 11(2): 88-91.
[16]	Ader DN, Browne MW. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample[J]. Am J Obstet Gynecol, 1997, 177(1): 126-132.
[17]	Berek J, Novak E. Berek and Novak’s Gynecology, 15th ed[M]. America: Lippincott Williams and Wilkins, 2012: 668.
[18]	Hadi MS. Sports Brassiere: is it a solution for mastalgia?[J]. Breast J, 2000, 6(6): 407-409.
[19]	Srivastava A, Mansel RE, Arvind N, et al. Evidence-based management of Mastalgia: A Meta-analysis of randomised trials[J]. Breast, 2007, 16(5): 503-512.
[20]	Kataria K, Dhar A, Srivastava A, et al. A systematic review of current understanding and management of mastalgia[J]. Indian J Surg, 2014, 76(3): 217-222.
[21]	Mansel RE, Goyal A, Preece P, et al. European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia[J]. Am J Obstet Gynecol, 2004, 191(6): 1942-1949.
[22]	马瑞，张丹，林从尧. 小金丸、逍遥丸及乳癖散结胶囊治疗乳腺增生的临床观察[J]. 现代中西医结合杂志, 2015, 24(2): 140-142.
[23]	孙利昆，柳芳，陈文倩, 等. 基于Meta分析的小金丸治疗乳腺增生疗效评价[J]. 中国药物评价, 2016, 33(5): 448-451, 456.

项目	危险因素
人口特征	高龄、肥胖或超重（尤其是绝经后）
病史	BRCA1或BRCA2基因突变、一级亲属患有乳腺癌或卵巢癌家属史、不典型增生或者小叶原位癌病史、≥1次乳腺穿刺病史（根据穿刺病理结果）、乳腺癌或卵巢癌病史
药物和饮食习惯	饮酒史、既往或目前正在进行激素替代治疗或口服避孕药史
生育史	初潮≤12岁，绝经≥55岁、未生育或者初产年龄≥35岁
其他	乳腺钼靶显示高密度史、前胸部射线暴露史

项目	危险因素
人口特征	高龄、肥胖或超重（尤其是绝经后）
病史	BRCA1或BRCA2基因突变、一级亲属患有乳腺癌或卵巢癌家属史、不典型增生或者小叶原位癌病史、≥1次乳腺穿刺病史（根据穿刺病理结果）、乳腺癌或卵巢癌病史
药物和饮食习惯	饮酒史、既往或目前正在进行激素替代治疗或口服避孕药史
生育史	初潮≤12岁，绝经≥55岁、未生育或者初产年龄≥35岁
其他	乳腺钼靶显示高密度史、前胸部射线暴露史

Please choose a citation manager

Content to export